June 27th – June 30th, 2019, Cambridge, Boston, USA
Cardiovascular Research @ Bayer
Are you an emerging scientist focusing on cardiovascular or lung research and are driven to improve people`s lives? Then join our scientific workshop “Cardiovascular Research @ Bayer” and connect with Bayer!
Bayer has long-standing experience in identifying and validating drug targets in various cardiovascular and lung indications, developing therapeutics and bringing those to the market, and is strongly committed to continuing cardiovascular and lung research in the future. Thus, Bayer is continuously interested in identifying talented scientists who are keen to make an impact, have the passion to innovate and are interested in a career in cardiovascular research within an industry setting.
Bayer offers a broad spectrum of opportunities for scientists with a background in Biology, Biochemistry, Molecular Biology, Genetics, Bioinformatics, Data Science, Pharmacy or Medicine. As a Bayer postdoc, you will:
- Plan, execute and evaluate preclinical research and pharmacology studies in the field of cardiovascular diseases research, including the indications heart failure, arrhythmia, thrombosis, acute organ dysfunction, and kidney diseases and inflammatory and fibrotic lung diseases research.
- Be part of multidisciplinary project teams focusing on the identification of new drug targets and their validation, as well as the identification, optimization and characterization of therapeutics to enter preclinical studies
This workshop is an excellent opportunity to learn about pharmaceutical research and development and in particular Bayer`s engagement in developing therapeutics for cardiovascular and lung diseases.
As a participant, you will have the possibility to present your scientific experience and discuss the results of your own research with a Bayer expert. You will be able to interact and network with scientists and managers from Bayer’s R&D organization and discuss job opportunities, e.g. at our Precision Cardiology Lab in Cambridge, MA.
The event takes place at the “Royal Sonesta” in Cambridge, Massachusetts, USA. Within this global innovation hotbed, this venue provides a unique setting for scientific exchange. Ahead of the workshop we offer the possibility to attend a Symposium on Precision Medicine in Cardiovascular Diseases on June 27th, 2019.
At the workshop, you will be asked to present a scientific poster on your research from your previous or ongoing project. In addition, you will participate in Case Studies that allow you to dig into pharmaceutical drug development and discuss relevant scientific questions from Bayer’s business. Several talks about cardiovascular and lung research and data science at Bayer, our engagement in external innovation, experiences from Bayer staff scientists and your personal development opportunities will all familiarize you with the environment we offer to scientists joining us.
You are enthusiastic and deeply committed to cardiovascular and lung research. You are close to finishing or have just finished your PhD thesis and have a proven track record of your scientific achievements.
Preferably you have first-hand-experience in planning, executing and evaluating pharmacological studies. Knowledge of cardiovascular diseases (heart, vascular, thrombosis, acute organ disorders, kidney diseases) or experimental lung diseases is desirable, but not required.
You enjoy working in genuinely interdisciplinary teams and are able to connect experimental data to biological hypotheses and project decisions. Day by day, you enjoy learning new science and are driven to improve the quality of life, along with our mission: “Bayer: Science For A Better Life”.
Excellent communication skills in English are mandatory.
This video will show impressions of the Workshop “Cardiovascular Research @ Bayer” in April 2015.
Thank you very much for your interest in our Workshop "Cardiovascular Research @ Bayer". Please note that the application process is closed at present.
Please click here if you would like to receive a notification e-mail when the application process reopens.